MedTrace Logo

COVID-19 Effectiveness Study in the Philippines

NCT05518760 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-12-02

No results posted yet for this study

Summary

This is a multi-site, observational, prospective test negative design case-control study which primarily aims to determine the protective effectiveness of 2 doses of an inactivated COVID-19 vaccine at least 14 days after the second dose, against hospitalized virologically-confirmed SARS-CoV-2 infection.

Conditions

  • COVID-19
  • Vaccine Effectiveness Against COVID-19
  • Hospitalized COVID-19

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Coalition for Epidemic Preparedness Innovations

    collaborator OTHER

  • Mahidol Oxford Tropical Medicine Research Unit

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • University of the Philippines

    lead OTHER

Principal Investigators

  • Jacqueline Deen, MD, MSc · ICHHD, University of the Philippines - National Institutes of Health

  • Michelle Ylade, MD, MSc · ICHHD, University of the Philippines - National Institutes of Health

  • Kristal An C Agrupis, MD, MSc · ICHHD, University of the Philippines - National Institutes of Health

  • Maria Vinna Crisostomo, MD · ICHHD, University of the Philippines - National Institutes of Health

  • Jedas Veronica Daag, RN, RMT · ICHHD, University of the Philippines - National Institutes of Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2023-11-08
Completion
2024-03-15

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05518760 on ClinicalTrials.gov